News

Measles Cases Could Cost the U.S. Its Elimination Status. Here's What That Means.
Losing the status is a far bigger deal than most people likely know, and getting it back is no fast or easy feat.
There’s no vaccine for this
Her father told an interviewer that, no, he didn’t regret her vaccine status, and no, he had no plans to vaccinate his other ...
Zacks Small Cap Research on MSN1d
NNVC: NanoViricides Set to Initiate Phase 2 Trial in MPox
NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum ...
Adaptive Clinical Protocol Design for Phase II MPox Clade I Treatment with a Novel Broad-Spectrum Drug NV-387 is Almost Complete, Reports NanoViricides
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...
The future of child health: Innovations expanding access to immunization
Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...
How Public Health Discredited Itself
The signers acknowledged that leaders of their professions had previously condemned a street protest against lockdown ...